背景:迄今为止,肺癌是全世界最致命的诊断之一。有多种肺癌治疗方法和模式,通常在患者和医生咨询期间呈现。在医疗咨询过程中,实施决策工具以促进患者的决策和医疗保健过程的管理是至关重要的。研究表明,决策工具有助于促进肺癌患者在咨询过程中的健康管理和决策。I3LUNG项目当前工作的主要目的是系统地审查决策工具的实施情况,以促进有关肺癌患者肿瘤治疗的医疗咨询。
方法:在本研究中,我们遵循PRISMA指南进行了系统回顾.我们使用了基于电子计算机的搜索,涉及三个数据库,如下:Embase,PubMed,还有Scopus.10篇文章符合纳入标准,被纳入。他们明确地提到了肿瘤学背景下的决策工具,肺癌患者。
结果:讨论突出了关于肿瘤治疗的医疗咨询过程中决策辅助的积极作用的最令人鼓舞的结果,特别是关于焦虑,决策,病人的知识。然而,没有一个主要的决策辅助工具是必不可少的。选择最新的时间框架来选择符合条件的文章可能会阐明当前可用的决策辅助工具。
结论:未来的审查工作可以利用替代搜索策略,在医疗咨询期间探索其他肺癌特异性结局,以做出治疗决策和实施决策辅助工具。与肿瘤学领域的专家合作,患者决策,或健康交流可以为相关文献或研究方向提供有价值的见解和建议,这些文献或研究方向可能无法通过传统搜索方法轻松获取。制定未来研究指南的目的是促进针对患者需求的决策辅助。
BACKGROUND: To date, lung cancer is one of the most lethal diagnoses worldwide. A variety of lung cancer treatments and modalities are available, which are generally presented during the patient and doctor consultation. The implementation of decision tools to facilitate patient\'s decision-making and the management of their healthcare process during medical consultation is fundamental. Studies have demonstrated that decision tools are helpful to promote health management and decision-making of lung cancer patients during consultations. The main aim of the present work within the I3LUNG project is to systematically
review the implementation of decision tools to facilitate medical consultation about oncological treatments for lung cancer patients.
METHODS: In the present study, we conducted a systematic
review following the PRISMA guidelines. We used an electronic computer-based search involving three databases, as follows: Embase, PubMed, and Scopus. 10 articles met the inclusion criteria and were included. They explicitly refer to decision tools in the oncological context, with lung cancer patients.
RESULTS: The discussion highlights the most encouraging results about the positive role of decision aids during medical consultations about oncological treatments, especially regarding anxiety, decision-making, and patient knowledge. However, no one main decision aid tool emerged as essential. Opting for a more recent timeframe to select eligible articles might shed light on the current array of decision aid tools available.
CONCLUSIONS: Future
review efforts could utilize alternative search strategies to explore other lung cancer-specific outcomes during medical consultations for treatment decisions and the implementation of decision aid tools. Engaging with experts in the fields of oncology, patient decision-making, or health communication could provide valuable insights and recommendations for relevant literature or research directions that may not be readily accessible through traditional search methods. The development of guidelines for future research were provided with the aim to promote decision aids focused on patients\' needs.